1. PET-guided clinical trials in Hodgkin lymphoma: to agree or not to agree, that is the reviewer’s question

   • A. Gallamini
   • M. Meignan

   Editorial 12 October 2017 Pages: 1 - 3

2. Clinical impact of PSMA-based ¹⁸F–DCFBC PET/CT imaging in patients with biochemically recurrent prostate cancer after primary local therapy

   • Esther Mena
   • Maria L. Lindenberg
   • Baris Turkbey

   Original Article 11 September 2017 Pages: 4 - 11

   

3. PSMA targeted radioligandtherapy in metastatic castration resistant prostate cancer after chemotherapy, abiraterone and/or enzalutamide. A retrospective analysis of overall survival

   • K. Rahbar
   • M. Boegemann
   • H. Ahmadzadehfar

   Original Article 12 October 2017 Pages: 12 - 19

   

4. Clinical performance of ⁶⁸Ga-PSMA-11 PET/MRI for the detection of recurrent prostate cancer following radical prostatectomy

   • Benedikt Kranzbühler
   • Hannes Nagel
   • Irene A. Burger

   Original Article 14 October 2017 Pages: 20 - 30

   

5. Targeted alpha therapy of mCRPC: Dosimetry estimate of ²¹³Bismuth-PSMA-617

   • Clemens Kratochwil
   • Karl Schmidt
   • Frederik L. Giesel

   Original Article Open access 11 September 2017 Pages: 31 - 37

   

6. Improving quality of life in patients with pancreatic neuroendocrine tumor following peptide receptor radionuclide therapy assessed by EORTC QLQ-C30

   • Milka Marinova
   • Martin Mücke
   • Hojjat Ahmadzadehfar

   Original Article 01 September 2017 Pages: 38 - 46

   

7. Prognostic value of lymph node-to-primary tumor standardized uptake value ratio in endometrioid endometrial carcinoma

   • Hyun Hoon Chung
   • Gi Jeong Cheon
   • Yong Sang Song

   Original Article 21 August 2017 Pages: 47 - 55

   

8. Metabolic activity by ¹⁸F–FDG-PET/CT is predictive of early response after nivolumab in previously treated NSCLC

   • Kyoichi Kaira
   • Tetsuya Higuchi
   • Takayuki Asao

   Original Article 21 August 2017 Pages: 56 - 66

   

9. Comparison of ¹⁸F-FDG PET/MRI and MRI for pre-therapeutic tumor staging of patients with primary cancer of the uterine cervix

   • Theresia Sarabhai
   • Benedikt M. Schaarschmidt
   • Johannes Grueneisen

   Original Article 24 August 2017 Pages: 67 - 76

   

10. 18F–FDG PET/CT in solitary plasmacytoma: metabolic behavior and progression to multiple myeloma

    • Domenico Albano
    • Giovanni Bosio
    • Francesco Bertagna

    Original Article 19 August 2017 Pages: 77 - 84

    

11. Diagnostic and prognostic value of 18F-FDG PET/CT in recurrent germinal tumor carcinoma

    • Pierpaolo Alongi
    • Laura Evangelista
    • Maria Picchio

    Original Article 22 August 2017 Pages: 85 - 94

    

12. 18F-FDG-PET detects complete response to PD1-therapy in melanoma patients two weeks after therapy start

    • Ferdinand Seith
    • Andrea Forschner
    • Nina Schwenzer

    Short Communication 22 August 2017 Pages: 95 - 101

    

13. Added diagnostic value of respiratory-gated 4D 18F–FDG PET/CT in the detection of liver lesions: a multicenter study

    • Cinzia Crivellaro
    • Elena De Ponti
    • Luca Guerra

    Original Article 19 August 2017 Pages: 102 - 109

    

14. ⁸⁹Zr-labeled nivolumab for imaging of T-cell infiltration in a humanized murine model of lung cancer

    • Christopher G. England
    • Dawei Jiang
    • Weibo Cai

    Original Article 19 August 2017 Pages: 110 - 120

    

15. Imaging the multiple facets of immuno-oncology

    • Chaitanya Divgi

    Editorial Commentary 08 November 2017 Pages: 121 - 122

16. Targeting angiogenesis for radioimmunotherapy with a ¹⁷⁷Lu-labeled antibody

    • Emily B. Ehlerding
    • Saige Lacognata
    • Weibo Cai

    Original Article 18 August 2017 Pages: 123 - 131

    

17. PET and SPECT imaging of melanoma: the state of the art

    • Weijun Wei
    • Emily B. Ehlerding
    • Weibo Cai

    Review Article 30 October 2017 Pages: 132 - 150

    

18. Comment on “Comparison of CT and PET/CT for biopsy guidance in oncological patients”

    • Long Chen
    • Hua Sun

    Letter to the Editor 14 August 2017 Pages: 151 - 151

19. From fixed activities to personalized treatments in radionuclide therapy: lost in translation?

    • G. D. Flux
    • K. Sjogreen Gleisner
    • M. W. Konijnenberg

    Letter to the Editor Open access 27 October 2017 Pages: 152 - 154

20. EANM Springer Prizes awarded at EANM’ 17 Vienna

    Society Communications 04 November 2017 Pages: 155 - 156

    

21. Francesco Collamati, supervised by Riccardo Faccini: An intraoperative beta-probe for cancer surgery, Springer Theses

    • Gianluca De Matteis
    • Luigi Mansi

    Book Review 02 November 2017 Pages: 157 - 157

22. E. Edmund Kim, Hyung-Jun Im, Dong Soo Lee, Keon Wook Kang: Atlas and Anatomy of PET/MRI, PET/CT and SPECT/CT

    • Giuseppe Danilo Di Stasio
    • Luigi Mansi

    Book Review 02 November 2017 Pages: 158 - 158